	US 12,458,675 B2
	Compositions and methods for treating and managing chronic inflammatory skin disorders
Marc Cornell, San Jose, CA (US); and Barbara A. Paldus, San Jose, CA (US)
Assigned to CODEX LABS CORPORATION, San Jose, CA (US)
Filed by CODEX LABS CORPORATION, San Jose, CA (US)
Filed on Apr. 22, 2024, as Appl. No. 18/641,861.
Prior Publication US 2025/0325613 A1, Oct. 23, 2025
Int. Cl. A61K 36/00 (2006.01); A61K 9/00 (2006.01); A61K 36/185 (2006.01); A61K 36/28 (2006.01); A61K 36/30 (2006.01); A61K 47/18 (2017.01); A61K 47/36 (2006.01); A61P 17/18 (2006.01); A61P 29/00 (2006.01)

CPC A61K 36/30 (2013.01) [A61K 9/0014 (2013.01); A61K 36/185 (2013.01); A61K 36/28 (2013.01); A61K 47/18 (2013.01); A61K 47/36 (2013.01); A61P 17/18 (2018.01); A61P 29/00 (2018.01)]

20 Claims

1. A composition for application onto human skin comprising a synergistic blend of at least: (a) Calendula officinalis extract; (b) Symphytum officinale extract; and (c) Haberlea rhodopensis extract, wherein the composition is capable of effectively treating and managing symptoms associated with inflammatory skin disorders, and wherein (a), (b), and (c) are employed in a ratio by weight of about 2:1:1, respectively.